SOMX Financial Facts
Net loss: -4.47MLoss from operations: -4.48M
See Full Income Statement
Accrued liabilities: 5.41M
Other current assets: 586K
See Full Balance Sheet
Somaxon Pharmaceuticals (SOMX) Earnings
|
Expand Research on SOMX
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -25.5% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -1.4% | Normal Earnings Time | N/A |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
10/31/12 | Q312 | -$0.65 | -$0.35 | -$0.30 | $2.1M | $2.3M | N/A | Details | |||
5/10/12 | Q112 | -$0.04 | -$0.04 | $0.00 | $2.74M | $3.31M | N/A | Details | |||
3/8/12 | Q411 | -$0.21 | -$0.21 | $0.00 | $3.9M | $4.42M | N/A | Details | |||
11/3/11 | Q311 | -$0.36 | -$0.31 | -$0.05 | $3.7M | $4.55M | N/A | Details | |||
8/2/11 | Q211 | -$0.33 | -$0.36 | +$0.03 | $6.2M | $3.79M | N/A | Details | |||
5/3/11 | Q111 | -$0.38 | -$0.35 | -$0.03 | $2.2M | $2.22M | N/A | Details | |||
3/3/11 | Q410 | -$0.42 | -$0.40 | -$0.02 | $1.34M | $1.73M | N/A | Details |